Dynamic Neutrophil-to-Lymphocyte Ratio at 3-4 weeks of Intensity-Modulated Radiotherapy Combined with Normal Liver Volume Predicts Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma: A Retrospective Study

回顾性研究:强度调控放射治疗3-4周时动态中性粒细胞与淋巴细胞比值联合正常肝脏体积可预测肝细胞癌放射性肝损伤。

阅读:2

Abstract

PURPOSE: This study aimed to investigate whether early dynamic variation in circulating neutrophil-to-lymphocyte ratio(NLR) during intensity-modulated radiotherapy (IMRT) can predict radiation-induced hepatic toxicity (RIHT) in patients with hepatocellular carcinoma(HCC). PATIENTS AND METHODS: Neutrophil and lymphocyte counts of 103 HCC patients were measured every 2 weeks before, during and after completion of IMRT.Generalized estimating equations analyses was used to analyze the dynamic changes of neutrophil and lymphocyte counts. The prognostic significant factors were assessed through logistic regression analyses. Statistical power was assessed using power analysis, and the model was adjusted for multiple comparisons via the Bonferroni correction. Receiver operating characteristic (ROC) curves and calibration curves were used to evaluate the prediction accuracy.The predictive model was internally validated using 5-fold cross-validation. RESULTS: Radiation-induced liver disease(RILD) is a type of RIHT and is a relatively severe phenomenon of hepatic toxicity.Overall, 23 patients (22%) developed RILD. In RILD group, NLR were significantly changed in the first 3 to 4 weeks during IMRT (p=0.006).In multivariate analysis, NLR in first 3-4 weeks(NLR 4), the ratio of NLR in first 3-4 weeks to 1-2 weeks(NLR 4/2),and normal liver volume(NLV) were independent predictive factors for RILD. The area under the curve(AUC) was 0.860 (95% CI, 0.783-0.937).Larger NLV correlated with a lower likelihood of developing RILD(p = 0.041).The mean AUC values was 0.86 in the training set and 0.81 in the test sets across 5-fold cross-validation (p=0.41). CONCLUSION: Circulating NLR in first 3 to 4 weeks and its relatively change during IMRT were significantly associated with RIHT.The model based on early dynamic variation of NLR and dosimetric factors NLV can predict RIHT with high accuracy in HCC patients.It can timely assist clinician to take preventive measures and adjusting treatment plans.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。